IL165392A0 - Compositions and methods for liver growth and liver protection - Google Patents

Compositions and methods for liver growth and liver protection

Info

Publication number
IL165392A0
IL165392A0 IL16539203A IL16539203A IL165392A0 IL 165392 A0 IL165392 A0 IL 165392A0 IL 16539203 A IL16539203 A IL 16539203A IL 16539203 A IL16539203 A IL 16539203A IL 165392 A0 IL165392 A0 IL 165392A0
Authority
IL
Israel
Prior art keywords
liver
compositions
methods
growth
protection
Prior art date
Application number
IL16539203A
Other languages
English (en)
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of IL165392A0 publication Critical patent/IL165392A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1858—Platelet-derived growth factor [PDGF]
    • A61K38/1866—Vascular endothelial growth factor [VEGF]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
IL16539203A 2002-06-05 2003-06-05 Compositions and methods for liver growth and liver protection IL165392A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38663702P 2002-06-05 2002-06-05
PCT/US2003/017591 WO2003103581A2 (en) 2002-06-05 2003-06-05 Compositions and methods for liver growth and liver protection

Publications (1)

Publication Number Publication Date
IL165392A0 true IL165392A0 (en) 2006-01-15

Family

ID=29736189

Family Applications (2)

Application Number Title Priority Date Filing Date
IL16539203A IL165392A0 (en) 2002-06-05 2003-06-05 Compositions and methods for liver growth and liver protection
IL165392A IL165392A (en) 2002-06-05 2004-11-25 Use of vegfr modulator materials to prepare and protect liver growth drugs, products and kits that include them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL165392A IL165392A (en) 2002-06-05 2004-11-25 Use of vegfr modulator materials to prepare and protect liver growth drugs, products and kits that include them

Country Status (8)

Country Link
US (2) US7700571B2 (xx)
EP (2) EP1531676B1 (xx)
JP (2) JP5111729B2 (xx)
AU (1) AU2003251397B2 (xx)
CA (1) CA2486270C (xx)
HK (1) HK1076227A1 (xx)
IL (2) IL165392A0 (xx)
WO (1) WO2003103581A2 (xx)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1289565B1 (en) 2000-06-02 2015-04-22 Bracco Suisse SA Compounds for targeting endothelial cells
US8263739B2 (en) 2000-06-02 2012-09-11 Bracco Suisse Sa Compounds for targeting endothelial cells, compositions containing the same and methods for their use
US20050123925A1 (en) 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US7261876B2 (en) 2002-03-01 2007-08-28 Bracco International Bv Multivalent constructs for therapeutic and diagnostic applications
EP1587944A4 (en) 2002-03-01 2007-03-21 Dyax Corp KDR AND VEGF / KDR BINDING PEPTIDES AND THEIR USE FOR DIAGNOSTIC AND THERAPEUTIC PURPOSES
US7794693B2 (en) 2002-03-01 2010-09-14 Bracco International B.V. Targeting vector-phospholipid conjugates
US8623822B2 (en) 2002-03-01 2014-01-07 Bracco Suisse Sa KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy
IL165392A0 (en) * 2002-06-05 2006-01-15 Genentech Inc Compositions and methods for liver growth and liver protection
ES2385248T3 (es) * 2004-01-14 2012-07-20 Novahep Ab Células progenitoras hepáticas humanas y métodos de uso de las mismas
US8070703B2 (en) * 2004-03-10 2011-12-06 Vision Quest Industries Incorporated Electrically stimulating orthotic device and segmented liner
RU2380411C2 (ru) 2004-07-20 2010-01-27 Дженентек, Инк. Способ ингибирования пролиферации гепатоцитов, способ ингибирования клеточной адгезии гепатоцитов и способ ингибирования биологической активности angptl4 в гепатоцитах или предшественниках гепатоцитов
PL1869085T3 (pl) 2005-03-24 2012-09-28 Thrombogenics Nv Nowe przeciwciało anty-PIGF
DK1866414T3 (da) 2005-03-31 2012-04-23 Calando Pharmaceuticals Inc Inhibitorer af ribonukleotidreduktase-underenhed 2 og anvendelser deraf.
WO2007003609A1 (en) * 2005-06-30 2007-01-11 Vib Vzw Treatment of liver cirrhosis and its complications
NZ568809A (en) 2005-12-22 2011-08-26 Genentech Inc Recovering and purification of VEGF proteins from prokaryotic cells using polyanionic agents
MX2008012276A (es) * 2006-03-27 2008-10-08 Genentech Inc Metodos para el tratamiento de alteraciones del riñon.
US8685730B2 (en) * 2006-05-02 2014-04-01 Wisconsin Alumni Research Foundation Methods and devices for differentiating pluripotent stem cells into cells of the pancreatic lineage
CN101250498B (zh) * 2008-04-07 2010-06-09 南通大学附属医院 用载肝细胞生长因子聚乳酸-o-羧甲基壳聚糖纳米粒子的肝细胞培养方法
BRPI0920224A2 (pt) 2008-10-02 2017-06-27 Life Sciences Res Partners Vzw inibição de plgf para tratar leucemia positiva para cromossoma filadélfia
ES2788300T3 (es) * 2010-11-09 2020-10-21 Univ Cornell Regeneración hepática
PL2508207T3 (pl) * 2011-03-31 2013-09-30 Bioalliance Pharma Nanocząsteczki zawierające chemioterapeutyczny lek przeciwnowotworowy
WO2013033513A1 (en) 2011-08-31 2013-03-07 University Of Georgia Research Foundation, Inc. Apoptosis-targeting nanoparticles
EP2785739B1 (en) 2011-12-01 2017-03-15 ThromboGenics N.V. Improving trabeculectomy outcome
ES2669561T3 (es) 2012-02-17 2018-05-28 University Of Georgia Research Foundation, Inc. Nanopartículas para el transporte mitocondrial de agentes
US10398663B2 (en) 2014-03-14 2019-09-03 University Of Georgia Research Foundation, Inc. Mitochondrial delivery of 3-bromopyruvate
KR102461927B1 (ko) * 2016-02-17 2022-10-31 차의과학대학교 산학협력단 이식용 줄기세포 및 이를 포함하는 혈관신생의 유도 또는 촉진을 위한 이식용 약학 조성물
CN114224893B (zh) * 2022-01-25 2023-06-06 贵州省中国科学院天然产物化学重点实验室(贵州医科大学天然产物化学重点实验室) 喹唑啉衍生物在制备防治砷致肝损伤药物中的用途

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4399216A (en) 1980-02-25 1983-08-16 The Trustees Of Columbia University Processes for inserting DNA into eucaryotic cells and for producing proteinaceous materials
ZA811368B (en) 1980-03-24 1982-04-28 Genentech Inc Bacterial polypedtide expression employing tryptophan promoter-operator
NZ201918A (en) 1981-09-18 1987-04-30 Genentech Inc N-terminal methionyl analogues of bovine growth hormone
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
US4889818A (en) 1986-08-22 1989-12-26 Cetus Corporation Purified thermostable enzyme
US4892538A (en) 1987-11-17 1990-01-09 Brown University Research Foundation In vivo delivery of neurotransmitters by implanted, encapsulated cells
US5283187A (en) 1987-11-17 1994-02-01 Brown University Research Foundation Cell culture-containing tubular capsule produced by co-extrusion
US5217999A (en) 1987-12-24 1993-06-08 Yissum Research Development Company Of The Hebrew University Of Jerusalem Styryl compounds which inhibit EGF receptor protein tyrosine kinase
DE69105495T2 (de) 1990-04-02 1995-04-06 Pfizer Benzylphosphonsäure-tyrosinkinaseinhibitoren.
US5302606A (en) 1990-04-16 1994-04-12 Rhone-Poulenc Rorer Pharmaceuticals Inc. Styryl-substituted pyridyl compounds which inhibit EGF receptor tyrosine kinase
JPH06503095A (ja) 1991-05-29 1994-04-07 ファイザー・インコーポレーテッド 三環式ポリヒドロキシ系のチロシンキナーゼ阻害薬
US5227158A (en) 1991-06-10 1993-07-13 Genentech, Inc. Method of stimulating hepatocyte proliferation by administration of hepatocyte growth factor and gamma-interferon
GB9300059D0 (en) 1992-01-20 1993-03-03 Zeneca Ltd Quinazoline derivatives
WO1994003427A1 (en) 1992-08-06 1994-02-17 Warner-Lambert Company 2-thioindoles (selenoindoles) and related disulfides (selenides) which inhibit protein tyrosine kinases and which have antitumor properties
US6107046A (en) * 1992-10-09 2000-08-22 Orion Corporation Antibodies to Flt4, a receptor tyrosine kinase and uses thereof
US5330992A (en) 1992-10-23 1994-07-19 Sterling Winthrop Inc. 1-cyclopropyl-4-pyridyl-quinolinones
GB9226855D0 (en) 1992-12-23 1993-02-17 Erba Carlo Spa Vinylene-azaindole derivatives and process for their preparation
US6020473A (en) 1995-08-25 2000-02-01 Genentech, Inc. Nucleic acids encoding variants of vascular endothelial cell growth factor
WO1997009427A1 (en) * 1995-09-08 1997-03-13 Genentech, Inc. Vegf-related protein
US6100071A (en) 1996-05-07 2000-08-08 Genentech, Inc. Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
KR100634926B1 (ko) 1999-04-16 2006-10-17 제넨테크, 인크. 혈관 내피 세포 성장 인자 변이체 및 그의 용도
WO2000071713A1 (en) * 1999-05-20 2000-11-30 Scios Inc. Vascular endothelial growth factor variants
US20020164310A1 (en) * 2001-03-02 2002-11-07 Mgvs Ltd. Nucleic acid constructs, cells transformed therewith and methods utilizing same for inducing liver regeneration and alleviation of portal hypertension
US6659223B2 (en) * 2001-10-05 2003-12-09 Collins & Aikman Products Co. Sound attenuating material for use within vehicles and methods of making same
IL165392A0 (en) 2002-06-05 2006-01-15 Genentech Inc Compositions and methods for liver growth and liver protection

Also Published As

Publication number Publication date
AU2003251397A1 (en) 2003-12-22
JP5111729B2 (ja) 2013-01-09
EP1531676A4 (en) 2009-06-17
CA2486270A1 (en) 2003-12-18
EP1531676A2 (en) 2005-05-25
WO2003103581A2 (en) 2003-12-18
US20040170613A1 (en) 2004-09-02
EP2430923A1 (en) 2012-03-21
IL165392A (en) 2015-11-30
US7700571B2 (en) 2010-04-20
AU2003251397B2 (en) 2009-10-01
JP2005534648A (ja) 2005-11-17
CA2486270C (en) 2015-07-28
US7709455B2 (en) 2010-05-04
WO2003103581A3 (en) 2004-04-15
JP2010159266A (ja) 2010-07-22
EP1531676B1 (en) 2015-07-22
US20070122394A1 (en) 2007-05-31
HK1076227A1 (en) 2006-01-13

Similar Documents

Publication Publication Date Title
HK1076227A1 (en) Compositions and methods for liver growth and liver protection
EP1633718A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING TGF-S
HK1079122A1 (en) Compositions and methods for combination antiviraltherapy
AU2003298514A8 (en) Methods and compositions using cholinesterase inhibitors
GB0411940D0 (en) Methods and compositions
EP1545216A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING PATHOGENIC GROWTH
GB0606395D0 (en) Compositions and methods for sealing formations
EP1701725A4 (en) PROCESS AND COMPOSITIONS
AU2003256805A8 (en) Compounds compositions and methods
ZA200502843B (en) Methods and compositions for providing glutamine
AU2003207961A1 (en) Compositions and their use for enhancing and inhibiting fertilization
AU2003275268A8 (en) Hemostatic compositions and methods
EP1572991A4 (en) COMPOSITIONS AND METHODS OF HYDROXYLATING EPOTHILONES
AU2003297573A8 (en) Compositions and methods for treating transplants
ZA200502598B (en) Compositions and methods for inhibiting pathogenic growth
EP1662868A4 (en) COMPOSITION AND METHOD FOR HARVEST PROTECTION
AU2003295574A8 (en) Method and compositions for temporarily incapaciting subjets
EP1578944A4 (en) COMPOSITIONS AND METHODS FOR DEDICTING ASCENDING INFERENCES
AU2003275069A8 (en) Compositions and methods for preventing infection
AU2003303948A8 (en) Compositions and methods for preventing infection
AU2003275240A8 (en) Methods and compositions for soluble cpg15
EP1587405A4 (en) NEW COMPOSITIONS AND METHODS OF CANCER
AU2003210474A8 (en) Composition and method for inhibiting hypersensitivity
AU2003245524A8 (en) Cryosurgery compositions and methods
AU2003297181A8 (en) Compositions and methods for inhibiting tumor growth and metastasis